Biologic Therapy in Rheumatic Diseases cover logo

Episode 5: Novel Endpoints in RA Diagnosis and Management Monitoring Anemia, Fatigue, and Cardiovascular Status

16m · Biologic Therapy in Rheumatic Diseases · 01 Dec 11:03

Novel Endpoints in RA Diagnosis and Management: Monitoring Anemia, Fatigue, and Cardiovascular Status, features a telephone interview with Professor Iain McInnes.

The episode Episode 5: Novel Endpoints in RA Diagnosis and Management Monitoring Anemia, Fatigue, and Cardiovascular Status from the podcast Biologic Therapy in Rheumatic Diseases has a duration of 16:07. It was first published 01 Dec 11:03. The cover art and the content belong to their respective owners.

More episodes from Biologic Therapy in Rheumatic Diseases

Episode 6: Recent Advances in RA

Recent Advances in RA, features a telephone interview with Professor Josef Smolen

Episode 5: Novel Endpoints in RA Diagnosis and Management Monitoring Anemia, Fatigue, and Cardiovascular Status

Novel Endpoints in RA Diagnosis and Management: Monitoring Anemia, Fatigue, and Cardiovascular Status, features a telephone interview with Professor Iain McInnes.

Episode 4: Treatment Needs in Patients with Psoriatic Arthitis features a telephone interview with Professor Douglas Veale

Treatment Needs in Patients with Psoriatic Arthitis features a telephone interview with Professor Douglas Veale

Episode 3: How Would Early Treatment Affect Disease and Quality-of-Life Outcomes in Spondyloarthritis (SpA)

This podcast, How Would Early Treatment Affect Disease and Quality-of-Life Outcomes in Spondyloarthritis (SpA)?, features a telephone interview with Professor Joachim Sieper.

Episode 2: Predicting the Onset and Disease Course of Rheumatoid Arthritis

This podcast, Predicting the Onset and Disease Course of Rheumatoid Arthritis, features a telephone interview with Professor Lars Klareskog.

Every Podcast » Biologic Therapy in Rheumatic Diseases » Episode 5: Novel Endpoints in RA Diagnosis and Management Monitoring Anemia, Fatigue, and Cardiovascular Status